AMN Healthcare Services Inc (AMN)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $1.47B
Last updated: Nov 17, 2026 at 11:05 AM ET
AMN Healthcare Services Inc (AMN) Financials: Revenue, Profit and Cash Flow
AMN Healthcare Services reported revenue of $2.73B for the fiscal year ended Dec 31, 2025, down 8.5% from the year before. That year, net income was -$95.70M with a net margin of -3.5%, operating cash flow was $269.46M and free cash flow was $233.83M. The quarter ended Sep 30, 2026 had revenue of $717.27M and net income of $33.39M.
Revenue and Margins
The operating margin was -2.0% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $1.90B, a compound annual rate of 4.1%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $2.73B | -8.5% | 28.3% | -2.0% | -3.5% |
| Dec 2024 | $2.98B | -21.3% | 30.8% | -3.4% | -4.9% |
| Dec 2023 | $3.79B | -27.7% | 33.0% | 8.9% | 5.6% |
| Dec 2022 | $5.24B | +31.6% | 32.7% | 12.3% | 8.5% |
| Dec 2021 | $3.98B | +66.4% | 32.9% | 12.0% | 8.2% |
| Dec 2020 | $2.39B | +7.7% | 33.1% | 6.2% | 3.0% |
| Dec 2019 | $2.22B | +4.0% | 33.5% | 8.0% | 5.1% |
| Dec 2018 | $2.14B | +7.4% | 32.6% | 9.5% | 6.6% |
| Dec 2017 | $1.99B | +4.5% | 32.4% | 10.7% | 6.7% |
| Dec 2016 | $1.90B | N/A | 32.6% | 10.1% | 5.6% |
Income Statement
In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, net income rose 14.0% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.73B | $2.98B | $3.79B | $5.24B | $3.98B | $2.39B | $2.22B | $2.14B | $1.99B | $1.90B |
| Cost of revenue | $1.96B | $2.06B | $2.54B | $3.53B | $2.67B | $1.60B | $1.48B | $1.44B | $1.34B | $1.28B |
| Gross profit | $774.06M | $919.38M | $1.25B | $1.72B | $1.31B | $791.78M | $743.47M | $696.38M | $644.42M | $619.72M |
| Operating income | -$55.47M | -$102.67M | $338.43M | $647.10M | $478.00M | $149.26M | $176.91M | $202.83M | $212.44M | $191.63M |
| Net income | -$95.70M | -$146.98M | $210.68M | $444.05M | $327.39M | $70.67M | $113.99M | $141.74M | $132.56M | $105.84M |
| EBITDA | $101.13M | $71.11M | $499.36M | $784.21M | $581.70M | $243.45M | $235.14M | $243.86M | $244.59M | $221.25M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $717.27M | $673.24M | $1.38B | $748.23M | $634.50M | $658.17M | $689.53M | $734.71M | $687.51M | $740.68M | $820.88M | $818.27M |
| Gross profit | $229.12M | $205.88M | $368.84M | $195.13M | $184.41M | $196.40M | $198.12M | $218.99M | $213.06M | $229.83M | $257.51M | $260.95M |
| Operating income | $50.52M | $26.91M | $117.17M | $8.12M | $47.62M | -$123.72M | $12.51M | -$202.55M | $22.25M | $37.68M | $39.95M | $34.17M |
| Net income | $33.39M | $21.16M | $62.17M | -$7.70M | $29.29M | -$116.20M | -$1.09M | -$187.53M | $6.99M | $16.24M | $17.33M | $12.49M |
Balance Sheet
As of Dec 2025, total debt of $773.06M exceeded cash and equivalents by $739.09M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.09B | $2.42B | $2.92B | $2.89B | $3.13B | $2.35B | $1.93B | $1.49B | $1.25B | $1.19B |
| Current assets | $545.38M | $594.91M | $841.68M | $1.09B | $1.35B | $533.74M | $560.50M | $482.17M | $474.15M | $450.63M |
| Cash and equivalents | $33.97M | $10.65M | $32.94M | $64.52M | $180.93M | $29.21M | $82.98M | $13.86M | $15.15M | $10.62M |
| Total liabilities | $1.45B | $1.71B | $2.09B | $1.84B | $1.97B | $1.53B | $1.19B | $853.73M | $691.43M | $737.50M |
| Short-term debt | $6.01M | $6.20M | $7.99M | $8.09M | $11.38M | $4.69M | $0 | $202.23M | $178.54M | $3.75M |
| Long-term debt | $767.05M | $1.06B | $1.30B | $843.50M | $842.32M | $857.96M | $617.16M | $440.61M | $319.84M | $359.19M |
| Shareholder equity | $642.11M | $706.62M | $831.26M | $1.04B | $1.16B | $819.68M | $736.74M | $638.99M | $562.53M | $449.38M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.29B | $2.36B | $2.60B | $2.09B | $2.14B | $2.21B | $2.40B | $2.42B | $2.67B | $2.77B | $2.87B | $2.92B |
| Total liabilities | $1.52B | $1.62B | $1.89B | $1.45B | $1.49B | $1.60B | $1.68B | $1.71B | $1.78B | $1.89B | $2.02B | $2.09B |
| Cash and equivalents | $255.98M | $361.84M | $560.74M | $33.97M | $52.64M | $41.50M | $55.78M | $10.65M | $30.55M | $48.04M | $50.56M | $32.94M |
| Shareholder equity | $775.01M | $741.28M | $712.81M | $642.11M | $644.41M | $607.60M | $715.05M | $706.62M | $890.66M | $876.86M | $854.19M | $831.26M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 86.8% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $269.46M | $320.42M | $372.17M | $653.73M | $305.36M | $256.83M | $224.86M | $226.99M | $160.52M | $133.91M |
| Capital expenditures | $35.63M | $80.89M | $103.69M | $75.83M | $53.57M | $37.70M | $35.22M | $35.21M | $26.53M | $21.96M |
| Free cash flow | $233.83M | $239.53M | $268.48M | $577.90M | $251.78M | $219.12M | $189.64M | $191.79M | $133.99M | $111.95M |
| Share repurchases | $0 | $0 | $424.74M | $576.77M | $2.69M | $0 | $18.70M | $67.01M | $20.16M | $13.26M |
| Investing cash flow | $4.30M | -$79.94M | -$412.49M | -$170.71M | -$107.40M | -$538.17M | -$291.82M | -$279.34M | -$35.36M | -$258.36M |
| Financing cash flow | -$295.89M | -$259.45M | $10.73M | -$591.87M | -$34.90M | $211.49M | $136.60M | $37.51M | -$77.19M | $126.29M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$87.53M | -$189.93M | $562.45M | $75.57M | $22.67M | $78.55M | $92.67M | $72.81M | $66.70M | $99.52M | $81.39M | -$41.13M |
| Capital expenditures | $9.81M | $8.53M | $7.25M | $7.95M | $7.91M | $9.80M | $9.97M | $16.22M | $19.26M | $27.27M | $18.14M | $29.86M |
| Free cash flow | -$97.33M | -$198.46M | $555.21M | $67.63M | $14.76M | $68.75M | $82.70M | $56.59M | $47.44M | $72.25M | $63.24M | -$70.99M |
Frequently Asked Questions About AMN
What is AMN Healthcare Services' annual revenue?
AMN Healthcare Services reported revenue of $2.73B for the fiscal year ended Dec 31, 2025.
How fast is AMN Healthcare Services' revenue growing?
Revenue was down 8.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -19.5%.
Is AMN Healthcare Services profitable?
No. AMN Healthcare Services reported net income of -$95.70M for the fiscal year ended Dec 31, 2025, with a net margin of -3.5%.
How much free cash flow does AMN generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $269.46M minus capital expenditures of $35.63M produced free cash flow of $233.83M.
How much debt does AMN Healthcare Services have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $767.05M, short-term debt of $6.01M and cash and equivalents of $33.97M.
AMN pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts